Bird & Bird’s intellectual property practice in Hong Kong SAR provides a comprehensive offering across the Asia-Pacific region. The China Group is spread across the firm’s offices in Hong Kong, Beijing and Shanghai and comprises of six partners and over 50 professionals. The group’s industry expertise lies within the fields of technology and innovation, including life sciences and healthcare sectors.
Hong Kong-based partner Matthew Laight heads the firm’s IP practice in the Asia-Pacific region. He specialises in both contentious and non-contentious matters, advising clients across a broad range of sectors including electronics, pharmaceuticals, media, and food and beverages. Partner Ted Chwu co-heads the global technology and communications sector group. He has extensive experience in commercial IP matters.
Partner Alison Wong is advising a multinational US-headquartered biotechnology company in analysing the IP and regulatory position for its blockbuster drug in Hong Kong, China and other jurisdictions in Asia-Pacific.